Treatment Options

Here's what the clinical trials actually found — effect sizes, not marketing. Your clinician uses this same evidence to build your treatment plan.

Hormonal (Rx)

Systemic Estrogen Therapy

Oral or transdermal estrogen for vasomotor symptoms. Most effective treatment for hot flashes and night sweats.

Evidence

~75% reduction in hot flash frequency (multiple RCTs)

Considerations

Requires progesterone if uterus is intact. Contraindicated in active breast cancer, unexplained vaginal bleeding, history of VTE.

Local (Vaginal) Estrogen

Low-dose vaginal estrogen for GSM symptoms. Minimal systemic absorption.

Evidence

Significant improvement in vaginal atrophy within 4-12 weeks (RCTs)

Considerations

Generally considered safe even in some populations where systemic estrogen is contraindicated. Discuss with clinician.

Progesterone / Progestins

Required with systemic estrogen if uterus is intact. Micronized progesterone preferred by many clinicians.

Evidence

Uterine protection established. Micronized progesterone may have fewer side effects than synthetic progestins.

Considerations

Formulation and route matter for risk profile.

Non-Hormonal (Rx)

Fezolinetant (Veozah)

NK3 receptor antagonist. First non-hormonal Rx specifically approved for vasomotor symptoms.

Evidence

40-60% reduction in hot flash frequency (Phase 3 trials)

Considerations

FDA-approved 2023. Option for women who cannot or prefer not to use hormones.

SSRIs / SNRIs

Certain antidepressants (paroxetine, venlafaxine) reduce hot flash frequency.

Evidence

Moderate efficacy (30-60% reduction). Paroxetine is FDA-approved for VMS.

Considerations

May help with concurrent mood symptoms. Side effect profile varies.

Lifestyle & Non-Rx

Cognitive Behavioral Therapy (CBT)

Structured therapy targeting the cognitive and behavioral response to symptoms.

Evidence

RCTs show CBT reduces the perceived impact of hot flashes and improves sleep quality.

Considerations

Does not reduce frequency of hot flashes but significantly improves coping and quality of life.

Exercise & Weight Management

Regular physical activity may reduce symptom severity and improve overall wellbeing.

Evidence

Moderate evidence for improvement in sleep, mood, and cardiovascular health. Limited evidence for direct hot flash reduction.

Considerations

Benefits extend well beyond menopause symptoms. No contraindications.

Reading the evidence is step one. Step two is a clinician who's read it too — and has time to explain what it means for you specifically.

Start your assessment

If your clinician determines treatment isn't appropriate, you get a full refund — not a prescription you don't need. Individual results vary. Treatment decisions are based on your medical history.